Stillwater Investment Management, LLC Gilead Sciences, Inc. Transaction History

Stillwater Investment Management, LLC

$372 Million
Q1 2023

A detailed history of Stillwater Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Stillwater Investment Management, LLC holds 39,201 shares of GILD stock, worth $3.54 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

39,201

Previous 38,737 1.2%

Holding current value

$3.54 Million

Previous $3.33 Million 2.2%

% of portfolio

0.87%

Previous 0.94%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 05, 2023	BUY	$77.31 - $88.08 $35,871 - $40,869	464 Added 1.2%	39,201 $3.25 Million
Q4 2022 Jan 10, 2023	BUY	$62.32 - $89.47 $19,942 - $28,630	320 Added 0.83%	38,737 $0
Q3 2022 Oct 05, 2022	BUY	$59.54 - $68.01 $25,542 - $29,176	429 Added 1.13%	38,417 $2.37 Million
Q2 2022 Jul 05, 2022	SELL	$57.72 - $65.01 $30,764 - $34,650	-533 Reduced 1.38%	37,988 $2.35 Million
Q1 2022 Apr 04, 2022	BUY	$57.92 - $72.58 $4,344 - $5,443	75 Added 0.2%	38,521 $2.29 Million
Q4 2021 Jan 04, 2022	BUY	$64.88 - $73.64 $27,314 - $31,002	421 Added 1.11%	38,446 $2.79 Million
Q3 2021 Oct 04, 2021	BUY	$67.69 - $73.03 $16,042 - $17,308	237 Added 0.63%	38,025 $2.66 Million
Q2 2021 Jul 01, 2021	SELL	$63.47 - $69.35 $9,774 - $10,679	-154 Reduced 0.41%	37,788 $2.6 Million
Q1 2021 Apr 02, 2021	BUY	$60.0 - $68.46 $58,140 - $66,337	969 Added 2.62%	37,942 $2.45 Million
Q4 2020 Jan 04, 2021	SELL	$56.65 - $64.55 $213,740 - $243,547	-3,773 Reduced 9.26%	36,973 $2.15 Million
Q3 2020 Oct 05, 2020	BUY	$62.1 - $78.08 $36,949 - $46,457	595 Added 1.48%	40,746 $2.58 Million
Q2 2020 Jul 06, 2020	BUY	$72.34 - $84.0 $33,638 - $39,060	465 Added 1.17%	40,151 $3.09 Million
Q1 2020 Apr 03, 2020	BUY	$62.63 - $80.22 $33,632 - $43,078	537 Added 1.37%	39,686 $2.97 Million
Q4 2019 Jan 03, 2020	BUY	$61.62 - $67.78 $13,679 - $15,047	222 Added 0.57%	39,149 $2.54 Million
Q3 2019 Oct 02, 2019	SELL	$62.51 - $69.0 $43,194 - $47,679	-691 Reduced 1.74%	38,927 $2.47 Million
Q2 2019 Jul 03, 2019	SELL	$61.87 - $69.38 $182,516 - $204,671	-2,950 Reduced 6.93%	39,618 $2.68 Million
Q1 2019 Apr 03, 2019	BUY	$62.53 - $70.05 $43,520 - $48,754	696 Added 1.66%	42,568 $2.77 Million
Q4 2018 Jan 04, 2019	SELL	$60.54 - $79.0 $109,637 - $143,069	-1,811 Reduced 4.15%	41,872 $2.62 Million
Q3 2018 Oct 03, 2018	BUY	$71.28 - $78.92 $9,408 - $10,417	132 Added 0.3%	43,683 $3.37 Million
Q2 2018 Jul 05, 2018	BUY	$64.88 - $75.68 $16,868 - $19,676	260 Added 0.6%	43,551 $3.09 Million
Q1 2018 Apr 04, 2018	BUY	$72.84 - $88.8 $188,291 - $229,548	2,585 Added 6.35%	43,291 $3.26 Million
Q4 2017 Jan 04, 2018	BUY	$71.15 - $83.52 $238,708 - $280,209	3,355 Added 8.98%	40,706 $2.92 Million
Q3 2017 Oct 04, 2017	BUY	$72.11 - $85.47 $2.69 Million - $3.19 Million	37,351	37,351 $3.03 Million

Others Institutions Holding GILD

# of Institutions

1,904

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stillwater Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stillwater Investment Management, LLC with notifications on news.

Account

Stillwater Investment Management, LLC Gilead Sciences, Inc. Transaction History